(October 1, 2015) A new study published in the Journal of Clinical Oncology shows that women with the most common type of ovarian cancer can safely take hormone replacement therapy (HRT), and it could have a beneficial effect on their survival. The 24-year, phase III international trial provides the strongest evidence yet that women with … Continued
By Annie Ellis: On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA). This meeting was co-sponsored by the Society of Gynecologic Oncology (SGO), the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). Click plus sign to read more.
By Annie Ellis On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA). This meeting was co-sponsored by the Society of Gynecologic Oncology (SGO), the … Continued
This #30DaysofTeal, you helped us give ovarian cancer the spotlight over 1 million times-THANK YOU! But #30DaysofTeal doesn’t stop today…We Teal year round for the everyone affected by ovarian cancer, so keep spreading awareness and the Teal love.
Today we are excited to announce the creation of the Congressional Ovarian Cancer Caucus, a group of lawmakers in Washington, DC committed to advancing awareness and research in ovarian cancer. Please help us build this important movement and ask your Member of Congress to join the Caucus today. http://cqrcengage.com/ovarian/app/write-a-letter?7&engagementId=130619
Family history also contributes to a woman’s risk of ovarian cancer. Women who have one first-degree relative with ovarian cancer but no known genetic mutation still have an increased risk of developing ovarian cancer. The lifetime risk of a woman who has a first degree relative with ovarian cancer is five percent (the average woman’s … Continued
Today marks the start of National Hereditary Breast and Ovarian Cancer Week and we’re encouraging all women to learn their risk for Hereditary Breast and Ovarian Cancer. Did you know these two diseases are linked, especially for women with mutations in the BRCA1 and BRCA2 genes. Not sure if you might have a mutation? The … Continued
All month long we have been celebrating caregivers in our community. Today we are sharing the story of Donella and her mom Dorothey. Dorothey was experiencing the symptoms of ovarian cancer and her general doctor advised to limit her salt intake. Donella, took action and became an advocate for her mom, researching her symptoms and … Continued
The National Comprehensive Cancer Network Guidelines for Ovarian Cancer can help walk you through all aspects of an ovarian cancer diagnosis. It answers questions from before a diagnosis through the whole cancer care continuum. You can use this guide as a way to learn more and go back to your doctor with questions you might … Continued
Are you interested in making a difference in the lives of women with ovarian cancer? Become an Advocate Leader in 2016! Our Advocate Leaders are a group of highly trained individuals who advance the interests of women with ovarian cancer at the local, state and federal levels. The Advocate Leaders have raised awareness through news … Continued
The past few years have seen significant changes to healthcare across the United States with the implementation of the Affordable Care Act, including some great progress made for women at risk of and with ovarian cancer. While we have made good strides in state policies, there is still a lot of work to be done. … Continued
Are you ready to look for a clinical trial? The Ovarian Cancer National Alliance offers a Clinical Trials Matching Service in partnership with Carebox. This one-stop service provides a comprehensive yet simplified system for women to find and link to clinical trial options for ovarian cancer. Find a clinical trial that’s right for you at … Continued
Get email updates about research news, action alerts, and ways to join the fight.
